Wave Neuroscience
14
2
2
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
7.1%
1 terminated/withdrawn out of 14 trials
91.7%
+5.2% vs industry average
7%
1 trials in Phase 3/4
64%
7 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder
Role: lead
eTMS for Veterans and First Responders With PTSD
Role: collaborator
Synchronized Transcranial Magnetic Stimulation for PTSD
Role: collaborator
EEG-based Personalized Transcranial Magnetic Stimulation (eTMS) to Treat Post-Traumatic Stress Disorder
Role: lead
EEG Personalized Transcranial Magnetic Stimulation (eTMS) for Post-Traumatic Stress Disorder
Role: lead
A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism
Role: lead
Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD
Role: lead
Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder
Role: lead
A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With ADHD
Role: lead
Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression
Role: lead
Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation for the Treatment of Generalized Anxiety Disorder
Role: collaborator
A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT
Role: lead
A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD
Role: lead
Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder
Role: lead
All 14 trials loaded